AtriCure Inc
ATRC40.330USD
-0.220-0.54%
收盘 12/26, 16:00（美东）报价延迟15分钟
2.00B总市值
亏损市盈率 TTM
关于 AtriCure Inc 公司
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
AtriCure Inc简介
公司代码ATRC
公司名称AtriCure Inc
上市日期Aug 05, 2005
CEOCarrel (Michael H)
员工数量1300
证券类型Ordinary Share
年结日Aug 05
公司地址7555 Innovation Way
城市MASON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编45040
电话15137554100
网址https://www.atricure.com
公司代码ATRC
上市日期Aug 05, 2005
CEOCarrel (Michael H)
AtriCure Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
702.94K
-0.85%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-6.15%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-6.78%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+32.18%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+41.20%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
702.94K
-0.85%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-6.15%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
United States
110.58M
81.23%
Europe
16.13M
11.85%
Asia
7.48M
5.50%
Other international
1.94M
1.42%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.71%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
其他
61.50%
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.71%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
其他
61.50%
股东类型
持股股东
占比
Investment Advisor
51.23%
Investment Advisor/Hedge Fund
39.51%
Hedge Fund
5.89%
Individual Investor
3.47%
Research Firm
1.65%
Pension Fund
0.79%
Bank and Trust
0.54%
Family Office
0.07%
Insurance Company
0.03%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
492
49.59M
116.79%
-102.71K
2025Q3
520
49.71M
119.25%
-705.98K
2025Q2
524
50.25M
121.23%
-1.55M
2025Q1
527
51.69M
113.33%
-4.41M
2024Q4
514
47.94M
122.38%
-3.05M
2024Q3
505
52.36M
125.18%
-207.95K
2024Q2
494
52.59M
116.92%
+1.07M
2024Q1
500
51.55M
109.93%
-1.63M
2023Q4
498
48.92M
106.78%
+1.54M
2023Q3
486
47.46M
108.31%
+99.25K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
4.90M
9.85%
+191.85K
+4.08%
Jun 30, 2025
Wellington Management Company, LLP
3.97M
7.99%
+3.27M
+465.38%
Jun 30, 2025
AllianceBernstein L.P.
3.57M
7.19%
-103.20K
-2.81%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.45M
6.94%
-124.60K
-3.49%
Jun 30, 2025
Hood River Capital Management LLC
3.06M
6.16%
+61.85K
+2.06%
Jun 30, 2025
Nomura Investment Management Business Trust
2.50M
5.04%
+66.37K
+2.72%
Jun 30, 2025
Champlain Investment Partners, LLC
2.02M
4.06%
-121.21K
-5.67%
Jun 30, 2025
State Street Investment Management (US)
1.27M
2.56%
-4.56K
-0.36%
Jun 30, 2025
Neuberger Berman, LLC
1.19M
2.39%
+3.67K
+0.31%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.18M
2.38%
+14.58K
+1.25%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Health Care Equipment ETF
1.75%
Harbor Human Capital Factor US Small Cap ETF
0.7%
Invesco NASDAQ Future Gen 200 ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.44%
Fidelity Enhanced Small Cap ETF
0.33%
Amplify Etho Climate Leadership U.S. ETF
0.3%
Franklin US Small Cap Multifactor Index ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.24%
iShares U.S. Medical Devices ETF
0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.17%
查看更多
State Street SPDR S&P Health Care Equipment ETF
占比1.75%
Harbor Human Capital Factor US Small Cap ETF
占比0.7%
Invesco NASDAQ Future Gen 200 ETF
占比0.5%
First Trust Small Cap Growth AlphaDEX Fund
占比0.44%
Fidelity Enhanced Small Cap ETF
占比0.33%
Amplify Etho Climate Leadership U.S. ETF
占比0.3%
Franklin US Small Cap Multifactor Index ETF
占比0.25%
JPMorgan Fundamental Data Science Small Core ETF
占比0.24%
iShares U.S. Medical Devices ETF
占比0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.17%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
AtriCure Inc的前五大股东是谁？
AtriCure Inc 的前五大股东如下：
The Vanguard Group, Inc.持有股份：4.90M，占总股份比例：9.85%。
Wellington Management Company, LLP持有股份：3.97M，占总股份比例：7.99%。
AllianceBernstein L.P.持有股份：3.57M，占总股份比例：7.19%。
BlackRock Institutional Trust Company, N.A.持有股份：3.45M，占总股份比例：6.94%。
Hood River Capital Management LLC持有股份：3.06M，占总股份比例：6.16%。
The Vanguard Group, Inc.持有股份：4.90M，占总股份比例：9.85%。
Wellington Management Company, LLP持有股份：3.97M，占总股份比例：7.99%。
AllianceBernstein L.P.持有股份：3.57M，占总股份比例：7.19%。
BlackRock Institutional Trust Company, N.A.持有股份：3.45M，占总股份比例：6.94%。
Hood River Capital Management LLC持有股份：3.06M，占总股份比例：6.16%。
AtriCure Inc的前三大股东类型是什么？
AtriCure Inc 的前三大股东类型分别是：
The Vanguard Group, Inc.
Wellington Management Company, LLP
AllianceBernstein L.P.
The Vanguard Group, Inc.
Wellington Management Company, LLP
AllianceBernstein L.P.
有多少机构持有AtriCure Inc(ATRC)的股份？
截至2025Q4，共有492家机构持有AtriCure Inc的股份，合计持有的股份价值约为49.59M，占公司总股份的116.79%。与2025Q3相比，机构持股有所增加，增幅为-2.47%。
哪个业务部门对AtriCure Inc的收入贡献最大？
在FY2025Q2，--业务部门对AtriCure Inc的收入贡献最大，创收--，占总收入的--%。
